A New Method for Bone Marrow Cell Harvesting

To minimize contamination of bone marrow cells (BMCs) with T cells from the peripheral blood, a new “perfusion method” for collecting BMCs is proposed using cynomolgus monkeys. Two BM puncture needles are inserted into a long bone such as the humerus, femur, or tibia. One needle is connected to an extension tube and the end of the tube is inserted into a culture flask to collect the BM fluid. The other needle is connected to a syringe containing 30 ml of phosphate‐buffered saline. The solution is pushed gently from the syringe into the medullary cavity, and the medium containing the BM fluid is collected into the culture flask. There is significantly less contamination with peripheral blood, determined from the frequencies of CD4+ and CD8+ T cells, when using this method (<6%) than when using the conventional method (>20%) consisting of multiple BM aspirations from the iliac crest. Furthermore, the number and progenitor activities of the cells harvested using this “perfusion method” are greater than those harvested using the conventional aspiration method. This perfusion method was carried out 42 times using 15 cynomolgus monkeys, and no complications such as pulmonary infarction or paralysis were observed. These findings suggest that the “perfusion method” is safe and simple and would be of great advantage in obtaining pure BMCs, resulting in a less frequent occurrence of acute graft‐versus‐host‐disease in allogeneic BM transplantation.

[1]  A. Marmont,et al.  Immune ablation followed by allogeneic or autologous bone marrow transplantation: A new treatment for severe autoimmune diseases? , 1994, Stem cells.

[2]  Pepe,et al.  Marrow transplantation from unrelated donors for treatment of hematologic malignancies: effect of mismatching for one HLA locus. , 1993, Blood.

[3]  R. Colvin,et al.  Modifications of the conditioning regimen for achieving mixed chimerism and donor-specific tolerance in cynomolgus monkeys. , 1997, Transplantation.

[4]  Thomas Ed,et al.  DOES BONE MARROW TRANSPLANTATION CONFER A NORMAL LIFE SPAN , 1999 .

[5]  D. Sachs,et al.  Mixed chimerism as an approach to transplantation tolerance. , 2000, Clinical immunology.

[6]  K. Matsuda,et al.  Development of a modified selective amplifier gene for hematopoietic stem cell gene therapy , 1999, Gene Therapy.

[7]  C. Ricordi,et al.  Analysis of post-transplant immune status in recipients of liver/bone marrow allografts. , 1999, Human immunology.

[8]  S. Masuda,et al.  HGF Activates Signal Transduction from EPO Receptor on Human Cord Blood CD34+/CD45+ Cells , 1999, Stem cells.

[9]  J. Hansen,et al.  Analysis of 462 transplantations from unrelated donors facilitated by the National Marrow Donor Program. , 1993, The New England journal of medicine.

[10]  E D Thomas,et al.  Does bone marrow transplantation confer a normal life span? , 1999, The New England journal of medicine.

[11]  K. Sullivan,et al.  Chronic graft-versus-host disease in 52 patients: adverse natural course and successful treatment with combination immunosuppression. , 1981, Blood.

[12]  K. Verbanac,et al.  The Facilitating Effect Of One‐Dr Antigen Sharing In Renal Allograft Tolerance Induced By Donor Bone Marrow In Rhesus Monkeys , 1995, Transplantation.

[13]  R Storb,et al.  Technique for human marrow grafting. , 1970, Blood.

[14]  A. Berger,et al.  Bone marrow transplantation for autoimmune diseases , 1999, BMJ.

[15]  S. Ikehara,et al.  Acceptance of skin allografts in pigs by portal venous injection of donor bone marrow cells. , 1999, Annals of surgery.